Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Assets (2016 - 2025)

Historic Assets for Gyre Therapeutics (GYRE) over the last 17 years, with Q3 2025 value amounting to $159.4 million.

  • Gyre Therapeutics' Assets rose 2726.29% to $159.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $159.4 million, marking a year-over-year increase of 2726.29%. This contributed to the annual value of $125.4 million for FY2024, which is 760.86% up from last year.
  • Per Gyre Therapeutics' latest filing, its Assets stood at $159.4 million for Q3 2025, which was up 2726.29% from $152.6 million recorded in Q2 2025.
  • Over the past 5 years, Gyre Therapeutics' Assets peaked at $159.4 million during Q3 2025, and registered a low of $10.0 million during Q3 2023.
  • Over the past 5 years, Gyre Therapeutics' median Assets value was $101.8 million (recorded in 2021), while the average stood at $88.8 million.
  • As far as peak fluctuations go, Gyre Therapeutics' Assets plummeted by 8513.43% in 2023, and later skyrocketed by 115692.49% in 2024.
  • Over the past 5 years, Gyre Therapeutics' Assets (Quarter) stood at $55.7 million in 2021, then soared by 52.26% to $84.8 million in 2022, then soared by 37.5% to $116.5 million in 2023, then grew by 7.61% to $125.4 million in 2024, then rose by 27.09% to $159.4 million in 2025.
  • Its Assets was $159.4 million in Q3 2025, compared to $152.6 million in Q2 2025 and $129.8 million in Q1 2025.